Atai Life Sciences Comprehensive Income 2020-2024 | ATAI
Atai Life Sciences comprehensive income from 2020 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
| Atai Life Sciences Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $-19 |
| 2022 | $-22 |
| 2021 | $-8 |
| 2020 | $6 |
| 2019 | $-1 |
| Atai Life Sciences Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-19 |
| 2024-03-31 | $-19 |
| 2023-12-31 | $-19 |
| 2023-09-30 | $-19 |
| 2023-06-30 | $-21 |
| 2023-03-31 | $-21 |
| 2022-12-31 | $-22 |
| 2022-09-30 | $-26 |
| 2022-06-30 | $-21 |
| 2022-03-31 | $-13 |
| 2021-12-31 | $-8 |
| 2021-09-30 | $-5 |
| 2021-06-30 | $4 |
| 2021-03-31 | $2 |
| 2020-12-31 | $6 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.208B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.379B | 12.93 |
| Quest Diagnostics (DGX) | United States | $17.308B | 17.75 |
| DaVita (DVA) | United States | $13.689B | 16.84 |
| Encompass Health (EHC) | United States | $9.303B | 22.88 |
| Chemed (CHE) | United States | $8.694B | 26.73 |
| Elanco Animal Health (ELAN) | United States | $7.242B | 16.28 |
| Option Care Health (OPCH) | United States | $5.321B | 26.14 |
| RadNet (RDNT) | United States | $4.963B | 117.74 |
| Amedisys (AMED) | United States | $3.181B | 22.75 |
| Astrana Health (ASTH) | United States | $2.805B | 39.69 |
| LifeStance Health (LFST) | United States | $2.579B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.399B | 29.12 |
| U.S Physical Therapy (USPH) | United States | $1.274B | 34.50 |
| Pennant (PNTG) | United States | $1.057B | 50.71 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.022B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.025B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |